Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
By Lori Solomon HealthDay Reporter
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing anterior cruciate ligament (ACL) reconstruction surgery, according to a study published online July 16 in the Journal of Bone & Joint Surgery.
Jonathan D. Packer, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues evaluated the impact of opioid-limiting perioperative pain management education and counseling on postoperative opioid consumption in patients aged 14 years and older. The analysis included 121 participants randomly assigned (1:1) either to receive opioid-limiting perioperative pain management education with instructions to take opioids only as a last resort or traditional perioperative pain management with instructions to take opioids as needed for severe pain to "stay ahead of the pain" (control group).
The researchers found that within three months after surgery, patients assigned to the treatment group consumed a mean of 46.0 mg of total morphine equivalents (TMEs) versus 63.6 mg of TMEs in the control group. The average score on the Numeric Rating Scale for pain in the first 14 days was similar between the groups (2.5 in the treatment group versus 2.4 in the control group). There were no significant differences between the groups for refill of oxycodone prescriptions within three months after surgery (four patients in the treatment group and six patients in the control group). The two groups were similar for sleep quality and patient satisfaction.
"This study provides convincing evidence that we should abandon the practice of counseling patients to take opioids to 'stay ahead of the pain' and counsel them to take them as a 'last resort' to manage pain," Packer said in a statement. "We believe that this approach is applicable to all surgeries, and we strongly recommend that clinicians consider adopting this simple strategy in their practice."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Low Rates of Isolated Locoregional Recurrence Seen in Young Women With Breast Cancer
TUESDAY, July 29, 2025 -- For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a...
Substance Use Disorder Linked to Higher Risk for Unplanned Readmissions
TUESDAY, July 29, 2025 -- People with any type of substance use disorder (SUD) face a higher risk for having an unplanned, 30-day hospital readmission compared with those without...
Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent
MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast cancer (BC) risk of 35 percent...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.